Máj- és epeúti rák: vizsgálatok itt: Brazília
11 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- No phaseTaking peopleObservational Study Protocol: LIVER-R
- Where
- Curitiba, Morumbi, Porto Alegre, Recife - PE, São Paulo
- Életkor
- 18 év to 130 év
- People
- 4000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06252753 - 3. fázisTaking peopleEfficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- Where
- Barretos, Jaú, Natal, Porto Alegre, Porto Alegrev, Rio de Janeiro, São José do Rio Preto
- Életkor
- 18 év and over
- People
- 286 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT06282575 · EU 2023-508219-21-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Barretos, Florianópolis, Jaú, Porto Alegre
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 3. fázisTaking peoplePhase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
- Where
- Natal, Porto Alegre, Santa Maria, São Paulo, Vitória
- Életkor
- 18 év to 99 év
- People
- 620 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06467357 · EU 2023-508057-19-00 - 3. fázisTaking peoplePhase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Where
- Barretos, Porto Alegre, Santa Maria, São Paulo, Vitória
- Életkor
- 18 év and over
- People
- 1220 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06921785 · EU 2024-518210-81-00 - No phaseTaking peopleSuprapapillary Metal Stent vs. Routine Transpapillary Drainage in Malignant Hilar Biliary Obstruction (SMART-B Trial)
- Where
- Porto Alegre
- Életkor
- 18 év and over
- People
- 84
- Run by
- Hospital de Clinicas de Porto Alegre
See details and how to joinNCT07558304 - 3. fázisTaking peopleA Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
- Where
- Barretos, Natal, Porto Alegre, Ribeirão Preto, São Paulo, Vitória
- Életkor
- 18 év and over
- People
- 1100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07221253 · EU 2025-523085-24-00 - 1/2. fázisTaking peopleA Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
- Where
- Barretos, Porto Alegre, Salvador, São José do Rio Preto, São Paulo
- Életkor
- 18 év and over
- People
- 630 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06427941 · EU 2025-524136-19-00 - 2. fázisTaking peopleStudy of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
- Where
- Cerqueira César, Curitiba, São José do Rio Preto, São Paulo
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT05727176 · EU 2023-503665-39-00 - 4. fázisTaking peopleEffect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Where
- Florianópolis, Natal, Passo Fundo, Porto Alegre, São Bernardo do Campo, São José do Rio Preto, São Paulo, Taguatinga
- Életkor
- 18 év to 64 év
- People
- 2076 worldwide
- Run by
- Guerbet
See details and how to joinNCT04373564 - No phaseNot yet taking people in BrazíliaProteomic Analysis of Patients Undergoing Bariatric Surgery
- Where
- Recife
- Életkor
- 18 év and over
- People
- 103
- Run by
- Universidade Federal de Pernambuco
See details and how to joinNCT06787807